Targeting regulation of stem cell exosomes: Exploring novel strategies for aseptic loosening of joint prosthesis

• Published in: Frontiers in bioengineering and biotechnology Vol. 10; p. 925841
• Main Authors: Ma, Tian-Liang, Chen, Jing-Xian, Ke, Zhuo-Ran, Zhu, Peng, Hu, Yi-He, Xie, Jie
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 10.08.2022
• Subjects: anti-inflammatory; aseptic loosening; Bioengineering and Biotechnology; bone metabolism; joint replacement; stem cell exosomes
• ISSN: 2296-4185; 2296-4185
• DOI: 10.3389/fbioe.2022.925841

Periprosthetic osteolysis is a major long-term complication of total joint replacement. A series of biological reactions caused by the interaction of wear particles at the prosthesis bone interface and surrounding bone tissue cells after artificial joint replacement are vital reasons for aseptic loosening. Disorder of bone metabolism and aseptic inflammation induced by wear particles are involved in the occurrence and development of aseptic loosening of the prosthesis. Promoting osteogenesis and angiogenesis and mediating osteoclasts and inflammation may be beneficial in preventing the aseptic loosening of the prosthesis. Current research about the prevention and treatment of aseptic loosening of the prosthesis focuses on drug, gene, and stem cell therapy and has not yet achieved satisfactory clinical efficacy or has not been used in clinical practice. Exosomes are a kind of typical extracellular vehicle. In recent years, stem cell exosomes (Exos) have been widely used to regulate bone metabolism, block inflammation, and have broad application prospects in tissue repair and cell therapy.